510(k) K792019
K792019 is an FDA 510(k) premarket notification submitted by Pharmaseal Div., Baxter Healthcare Corp. for the device "PHADECODE XA INHIBITOR ASSAY". The FDA issued a decision of Substantially Equivalent on Nov 5, 1979. The device falls under product code JBQ (Antithrombin Iii Quantitation), a Class II device regulated under 21 CFR 864.7060. Pharmaseal Div., Baxter Healthcare Corp. has 23 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 5, 1979
- Date Received
- Oct 9, 1979
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antithrombin Iii Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7060
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Pharmaseal Div., Baxter Healthcare Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.